Skip to content

Eeva™ Pregnancy Pilot Study (PPS)

Eeva™ Pregnancy Pilot Study (PPS)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02218255
Acronym
PPS
Enrollment
240
Registered
2014-08-18
Start date
2014-08-31
Completion date
2016-06-30
Last updated
2015-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

In Vitro Fertilization

Brief summary

The purpose of this clinical investigation is to gather pilot data to evaluate the impact of using Eeva™, a time-lapse enabled embryo test, in combination with traditional morphology on clinical pregnancy rates.

Interventions

DEVICEEeva™ results

Sponsors

Progyny, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Women undergoing fresh in vitro fertilization treatment using their own eggs * ≤ 40 years * ≥ 4 diploid embryos (i.e. having 2 PNs) * ≤ 3 Prior ART cycles (IVF, ICSI and related procedures) * All 2PN embryos (for all 3 arms) must be imaged by Eeva * Subject willing to comply with study protocol and procedures * Subject willing to provide written informed consent

Exclusion criteria

* Preimplantation genetic diagnosis or preimplantation genetic screening * Planned freeze all cycle (eggs or embryos) * Asherman's Syndrome * Donor egg * Gestational carrier * Presence of Hydrosalpinx on ultrasound * Concurrent participation in an interventional clinical study

Design outcomes

Primary

MeasureTime frame
Clinical Pregnancy7-8 weeks gestation

Secondary

MeasureTime frame
Ongoing pregnancy rate8-12 week gestation

Countries

United States

Contacts

Primary ContactMonica Ransom
mransom@auxogyn.com650-627-7604

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026